VRB-101
A Study of Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities
Verdiva Bio Dev Limited · Phase 2 · Terminated · Enrollment 8
Participants reaching threshold, %
Source: Cited trial source. The denominator is the source figure, when it states one.
No selected arm reports a responder percent.
Show as table
| Arm | ≥5% | ≥10% | ≥15% | ≥20% |
|---|---|---|---|---|
| VRB-101 (Active Arm 1) | n/r | n/r | n/r | n/r |
| VRB-101 (Active Arm 2) | n/r | n/r | n/r | n/r |
| VRB-101 (Active Arm 3) | n/r | n/r | n/r | n/r |
| Placebo | n/r | n/r | n/r | n/r |
Not shown
- VRB-101 (Active Arm 1): endpoint not reported
- VRB-101 (Active Arm 2): endpoint not reported
- VRB-101 (Active Arm 3): endpoint not reported
- Placebo: endpoint not reported